Market Trends– category –
-
US Government Expands Strategic Quantum Investments as Europe Prepares “EU Quantum Act” for Sovereignty
WisdomTree USA Overview The U.S. government is strategically expanding its investments in quantum technology, part of an intensifying global race for technological supremacy. Europe is also escalating its quantum ambitions, with France a... -
S&P Global Q2 Quantum Report Highlights IBM’s Nighthawk Processor and Logical Qubit Progress
S&P Global USA Overview S&P Global's Q2 2026 Quantum Quarterly report reveals significant progress by major hardware vendors targeting fault-tolerant quantum systems between 2027 and 2030. IBM is set to launch a 7,500-gate Nighthawk ... -
Samsung Biologics Expands to 845,000L Capacity with GSK Facility Acquisition; Lonza, Resilience Announce Major Investments Amidst CDMO Restructuring
DCAT Value Chain Insights USA, South Korea, Switzerland Overview The CDMO industry is undergoing unprecedented restructuring in 2026, driven by major strategic investments and M&A activities by leading players. Samsung Biologics acqu... -
Chemically Defined Media and Automation Key to Overcoming Raw Material Variability in Autologous Cell Therapies
BioProcess International International Overview Raw material variability poses a significant challenge to consistent manufacturing and quality in autologous adoptive cell therapies. Overcoming this requires chemically defined media, stan... -
Biologics CDMO Market to Reach $38.29 Billion by 2031, Fill-Finish Emerging as Key Segment
GlobeNewswire Global Overview This article provides an overview of a market research report from GlobeNewswire. The Biologics CDMO market is projected to grow from $27.13 billion in 2026 to $38.29 billion by 2031, exhibiting a CAGR of 7.... -
Point-of-Care Manufacturing Accelerates for Cell and Gene Therapies; Lonza Cocoon Sale Reshapes Industry Landscape
BioPharm International International Overview Point-of-care (PoC) manufacturing for biopharmaceuticals, particularly cell and gene therapies, is gaining momentum, with systems like Lonza's Cocoon and Miltenyi Biotec's CliniMACS Prodigy p... -
AI-Driven Innovation to Propel Industrial Biomanufacturing Market (2027-2037) Through Enzyme Discovery and Fermentation Optimization
IDTechEx (Report Summary) UK Overview This article provides an overview of a recent IDTechEx market research report, 'Industrial Biomanufacturing 2027-2037: Technologies, Markets, Players, Forecasts'. IDTechEx projects industrial biomanu... -
Stem Cell Engineering and Automation Propel Allogeneic Cell Therapy Market Towards $1.97 Billion by 2026
GlobeNewswire (via Report Summary) USA Overview A new market study by Open PR forecasts a robust expansion for the allogeneic cell therapy market, projecting it to reach $1.97 billion by 2026. This significant growth is attributed to adv... -
Commercial-Scale iPSC Cell Therapy: Advancements in Off-the-Shelf Treatments, Immunogenicity, and Cost Reduction are Key
The Medicine Maker UK Overview This article examines the challenges and technological advances in scaling induced pluripotent stem cell (iPSC) platforms for commercial cell therapies. It highlights the shift towards allogeneic, off-the-s... -
Perfusion Bioreactor Adoption Doubles to 65.8% Since 2016, Accelerating Shift to Continuous Biomanufacturing
synbio.intel USA Overview A BioPlan Associates survey from August 2026 reveals that single-use perfusion equipment usage has doubled to 65.8% across all production stages since 2016, indicating an accelerating shift towards continuous bi...
